SENS Research Foundation’s Post

In our nation’s journey towards harnessing the boundless potential of its burgeoning biotechnology sector, an obstacle looms large: the exodus of our brightest minds to foreign shores. This migration becomes the unseen anchor restraining the full realization of India's bioeconomic aspirations. At Xenesis, Absolute’s R&D core, we are humbled as scientists and advisors from top biotech destinations including USA, Europe, UK, Australia, and Israel, join us to propel our mission. These dynamic scientists may be divided by their niches, but stand united in pushing the boundaries of science. State-of-the-art research facilities, combined with the purpose of solving planet-scale challenges, drive our exponential biology-inspired outcomes. #Xenesis #Absolute #Research #biotechnology

Famous Project Manager: Craig Venter 🧬 Dr. Craig Venter, the biotechnologist and genomics pioneer, once said, "We are learning the language in which God created life." 💭🧬 Dr. Venter's words capture the profound implications of our growing ability to read, write, and edit the code of life through advances in genomics and synthetic biology. At Acute PMC, we help clients navigate the ethical and societal dimensions of frontier technologies. 💪🔬 From his historic achievement in creating the first cell with a synthetic genome to his current work at Synthetic Genomics, focused on using genomic tools to develop new vaccines, medicines, and clean energy solutions, Dr. Venter's projects are pushing the boundaries of what's possible with the building blocks of life. 🧬💡 How do you approach the ethical and societal considerations of cutting-edge technologies in your projects? Let us know in the comments! 💬 #FamousProjectManagers #CraigVenter #SyntheticBiology #DesignLife #FrontierEthics #AcutePMC

Jaime Castrellon honored by Association for Psychological Science https://lnkd.in/g8mQMJNM The post Jaime Castrellon honored by Association for Psychological Science appeared first on Life Sciences. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks #LosAngeles #OrangeCountyCA #Biotech #Lifescience #News

🎉It's the New Year, which means...a SUPER exciting announcement is right around the corner! The pipeline of potential treatments for #Duchenne #musculardystrophy has never been more promising, and we're thrilled to invite you to join our Research Grant Announcement on Thursday, January 25, 2024. Learn how your support is fueling transformative research and bringing us one step closer to life-changing breakthroughs: https://bit.ly/3tKELtS.

✨Certainly❗ Here👩🔬 are the most important ✍️research 🎓topics in 🧪biotechnology for 2024: 👉 👉Precision Medicine 💊and Personalized Therapeutics: Unlocking the Potential of Individualized 🏥Healthcare 👉Synthetic Biology and 👩🔬Bioengineering: Engineering Life for Tomorrow's Solutions 👉Microbiome🦠 Research: Deciphering the Microbial Universe: Implications for Health and Environment🏞️. 👉Circular Bioeconomy: Towards 🌿Sustainable Futures: Innovations in Bio-Based Industries🏭. 👉Neurotechnology and 🧠Brain-Computer🖥️ Interfaces: Bridging Minds and 💊Machines: Advancements in Neurological Interfaces #research #phdresearch #biotechnology #mscgraduate #researchstudy #scienceandtechnology #careerbuilding

" Even in the financial sector, the fusion of biological assets and blockchain technology might give birth to new forms of tradable, digital bio-assets, akin to NFTs. And let’s not overlook biosecurity; your biological data could become the ultimate secure form of identification. All of these avenues not only have the potential to improve our quality of life but also create entirely new opportunities for economic investment. As synthetic biology and AI technologies mature, they could deliver an impressive ROI — one not always measurable in dollars, but in a better life — making biology a compelling and increasingly accessible asset class for both individual and institutional investors. But given the complexity of these biological assets, it’s likely that a new breed of wealth managers, specialized in navigating the intricacies of bio-assets, will emerge to guide investment strategies. Overall, biology is not just the science of life anymore. It’s increasingly becoming an important asset class with unique investment opportunities and challenges, warranting its own strategies, risk assessments, and ethical considerations." By the way, this also has major dystopian hellscape elements . . . #financialservices #wealthmanagement

Earlier this year, we launched a pilot funding call for early-stage, visionary frontier bioscience research. We're now pleased to announce 62 pioneering new projects funded through the scheme. By drawing upon unconventional thinking and approaches, the investigators hope to make exciting discoveries with the potential to transform our understanding of the fundamental rules of life. Projects include: 🟣 Delving into the genetic mechanisms behind the regenerative abilities of the ‘immortal jellyfish’, led by Cardiff University / Prifysgol Caerdydd 🟣 Exploring the ‘starship’ molecules that may help fungi swap genes with each other, led by of University of Birmingham 🟣 Investigating a theoretical ‘third radical’ molecule that could help explain how migratory birds are so sensitive to Earth’s magnetic field, led by University of Exeter Professor Guy Poppy, Interim Executive Chair at BBSRC, said: “Understanding the fundamental rules of life, such as the principles governing genetics, evolution and biological processes, is essential for advancing scientific knowledge. It is also imperative to societal progress. Many of the challenges faced by today’s society, such as global food security, environmental sustainability and healthcare, are deeply rooted in biological processes. BBSRC is committed to understanding the rules of life by investing in cutting-edge discovery research through schemes like the Pioneer Awards pilot. Our investments are pivotal in expanding the horizons of human knowledge and helping to unlock innovative bio-based solutions to some of the world’s most pressing challenges.” Read a summary of all the projects: https://lnkd.in/egvx3geX

The Disrupt Dispatch Issue 24 - News on Nature-inspired Innovation! 🗞️ Read all about it! Market insights, case studies, books and videos from the world of nature-inspired innovation. In this issue: 👉 Find out who we formed a strategic partnership with. 👉 Start your learning journey with us with our new CPD-accredited course. 👉 How to predict the structure and interactions of all of life’s molecules. 👉 Where to learn more about bio-inspired materials in Switzerland. 👉 What are the European Space Agency up to in biomimetics? 👉 Discover Fairhaven, A Novel of Climate Optimism. 👉 How is Veryan Medical innovating in the MedTech space? Read + subscribe - https://bit.ly/3yeIxh4 With insights from Subcinctus Consulting, ESAC Group, Baretto Business Development, 42courses, The World Bank, Google DeepMind, Isomorphic Labs, Université de Fribourg - Universität Freiburg, European Space Agency - ESA, Veryan Medical, Steve Willis, Jan Lee, and us! #NatureInspiredInnovation #Biomimicry #Biomimetics #Bionics #Newsletter #WeekendReading ++ Hi, I'm Richard James MacCowan, the mind behind Biomimicry Innovation Lab. We partner with founders and leaders in #manufacturing, #agrifood and #urbantransformation sectors to turn ideas into reality, drawing inspiration from transformative solutions found in the living world. Our approach? Harnessing the latest scientific research to uncover your business challenges and align these with your unmet needs. Follow us to explore the power of nature-inspired innovation or reach out to dive deeper! 🦋

Glad to see months of hard work and collaboration coming into reality in the form of this year's Life Science Barometer! 📈 It also meant having the opportunity to look into regional naunces to the national results, especially since Skåne is the second-largest life science region in Sweden, representing 21% of life science companies in Sweden. What we found was: 🔎 Among the 820+ companies in Skåne, 560+ belonged to the core life science segments of pharma, biotech, medtech and diagnostics. 🔎 Medtech is also the largest segment in Skåne, representing 43% of companies. 🔎 Skåne has a higher proportion of micro-sized companies, 83%, compared to the Swedish average of 77%. 🔎 In the short term, finding and securing funding was a key priority for Skåne-based respondents (a pattern among micro-sized life science companies in Sweden), while... 🔎 In the long term, leadership recruitment and development is a prioritised area for increased investment after market growth and workforce recruitment. For those curious to find out more, I would encourage you to download the Life Science Barometer from SwedenBIO's website; do watch out as well for a regional report focused on Skåne that Medicon Village will publish later this spring, supported by Sparbanken Skåne.

Being able to repair myelin is a key step to help stop the progression of MS. Dr. Sally Wheatley and her team at the University of Nottingham are exploring just that. More specifically – they want to know if a protein called ‘survivin’ might affect myelin production. Why are researchers looking at this? A molecule inside cells (called SEH1) switches on genes to kick-start the production of myelin. Researchers think that when the survivin protein binds to SEH1, it could stop cells making myelin. If researchers find survivin reduces myelin production, it may help us find new treatments in the future. Find out more about Dr. Wheatley's research: https://mssoc.uk/4adE10j Dr. Wheatley’s research is funded by our Catalyst grants which give researchers the opportunity to explore new and innovative research projects: https://mssoc.uk/3TmNFGX